Abacavir (Strides Shasun Limited)


Welcome to the PulseAid listing for the Abacavir drug offered from Strides Shasun Limited. This Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Strides Shasun Limited
NON-PROPRIETARY NAME: Abacavir
SUBSTANCE NAME: ABACAVIR SULFATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2016-10-28
END MARKETING DATE: 0000-00-00


Abacavir HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAbacavir from Strides Shasun Limited
LABELER NAME: Strides Shasun Limited
DEA SCHEDULE:
ACTIVE STRENGTH: 300(1-Jan)
START MARKETING DATE: 2016-10-28
END MARKETING DATE: 0000-00-00
PRODUCT ID: 64380-717_124ca30e-ea2f-418c-a365-6e12d7363e70
PRODUCT NDC: 64380-717
APPLICATION NUMBER: ANDA091050

Other ABACAVIR SULFATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Health PackagingAbacavir
Apotex CorpAbacavir Sulfate
Aurobindo Pharma LimitedAbacavir
Avera McKennan HospitalAbacavir Sulfate
Camber Pharmaceuticals, Inc.Abacavir
Major PharmaceuticalsAbacavir Sulfate
Mylan Institutional Inc.Abacavir Sulfate
Mylan Pharmaceuticals Inc.Abacavir Sulfate
REMEDYREPACK INC.Abacavir Sulfate
State of Florida DOH Central PharmacyZIAGEN
Strides Shasun LimitedAbacavir
ViiV Healthcare CompanyZIAGEN